Balyasny Asset Management LLC Caribou Biosciences, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.62 - $5.05 $178,627 - $556,833
-110,264 Reduced 67.78%
52,419 $85,000
Q1 2024

May 13, 2024
BUY
$4.82 - $8.26 $784,132 - $1.34 Million
162,683 New
162,683 $836,000
Q2 2022

Aug 15, 2022
SELL
$5.1 - $9.74 $60,241 - $115,048
-11,812 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$8.42 - $15.32 $99,457 - $180,959
11,812 New
11,812 $108,000

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $91.9M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email